Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert

Glycemic control and quality of life following cataract surgery in diabetic patients

Search Title by author or title

Session Details

Session Title: Glaucoma & Posterior Segment

Session Date/Time: Monday 24/09/2018 | 08:00-10:30

Paper Time: 09:30

Venue: Room A3, Podium 1

First Author: : A.Achiron ISRAEL

Co Author(s): :    D. Bar-Oz   Y. Bar Dayan   I. Hecht   M. Midlij   V. Man   Z. Burgansky     

Abstract Details


To assess whether cataract surgery will improve glycemic control and quality of life in patients with diabetes


Wolfson medical center, Holon, Israel


A prospective longitudinal study of 28 patients with diabetes and without diabetic retinopathy scheduled for cataract removal surgery. During the 4 months of follow-up, measurements of HbA1c were obtained and assessment of quality of life was performed using two questionnaires: The EuroQoL 5-Dimension (EQ-5D®) and the Multidimensional Diabetes Questionnaire (MDQ).


HbA1c values decreased by approximately 0.45% following surgery (7.24% to 6.78%, P=0.009). Younger patients reduced HbA1c significantly more than older patients (0.73% vs. 0.03% respectively, P=0.043). Younger age also correlated with better visual acuity improvement (R=-0.44, P=0.02). Poor glycemic control prior to surgery correlated with better HbA1c reductions, with a 42%, 58%, and 72% chance for reduction of at least 0.5% HbA1c in patients with preoperative HbA1c values of 7.5%, 8.0% and 8.5% respectively. A 14% improvement following surgery was noted in the MDQ questionnaire results (33.9 vs. 38.7, P=0.034) but not in the EQ-5D®.


Cataract surgery may positively influence glycemic control and quality of life in diabetic patients. Younger patients and those with poor glycemic control or visual acuity may achieve superior visual and glycemic outcomes. The results of this study highlight the need for frequent inquiry regarding eyesight deterioration in patients with diabetes.

Financial Disclosure:


Back to previous